Amelioration of myocarditis by statin through inhibiting cross-talk between antigen presenting cells and lymphocytes in rats

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 6, 2008, Pages 1023-1031

  Wu, Jia lu ^a,b   Matsui, Shinobu ^a   Zong, Zhi ping ^a   Nishikawa, Katsuzo ^a   Sun, Bao gui ^b   Katsuda, Shogo ^a   Fu, Michael ^c  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antigen presenting cells; Cross talk; Lymphocytes; Myocarditis; Simvastatin

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; COCULTURE; CONTROLLED STUDY; HISTOPATHOLOGY; LYMPHOCYTE; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDITIS; RATS; RATS, INBRED LEW; SIMVASTATIN; SPLEEN; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 44649111169     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.03.016     Document Type: Article

References (51)

1. Vaughan C.J., and Gotto Jr. A.M. Update on statins: 2003. Circulation 110 (2004) 886-892
2. Nickenig G. Should angiotensin II receptor blockers and statins be combined?. Circulation 110 (2004) 1013-1020
3. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 109 23 Suppl 1 (2004) III39-III43
4. Kobashigawa J.A. Statins in solid organ transplantation: is there an immunosuppressive effect?. Am J Transplant 4 (2004) 1013-1018
5. Kobashigawa J.A., Katznelson S., Laks H., Johnson J.A., Yeatman L., Wang X.M., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
6. Neuhaus O., Stuve O., Zamvil S.S., and Hartung H.P. Are statins a treatment option for multiple sclerosis?. Lancet Neurol 3 (2004) 369-371
7. Gullu S., Emral R., Bastemir M., Parkes A.B., and Lazarus J.H. In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis. Eur J Endocrinol 153 (2005) 41-48
8. Weber M.S., Prod'homme T., Steinman L., and Zamvil S.S. Drug Insight: using statins to treat neuroinflammatory disease. Nat Clin Pract Neurol 1 (2005) 106-112
9. Leung B.P., Sattar N., Crilly A., Prach M., McCarey D.W., Payne H., et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 170 (2003) 1524-1530
10. Palmer G., Chobaz V., Talabot-Ayer D., Taylor S., So A., Gabay C., et al. Assessment of the efficacy of different statins in murine collagen-induced arthritis. Arthritis Rheum 50 (2004) 4051-4059
11. Greenwood J., Steinman L., and Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 6 (2006) 358-370
12. Neu N., Rose N.R., Beisel K.W., Herskowitz A., Gurri-Glass G., and Craig S.W. Cardiac myosin induced myocarditis in genetically predisposed mice. J Immunol 139 (1987) 3630-3636
13. Neu N., Ploier B., and Ofner C. Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J Immunol 145 (1990) 4094-4100
14. Ohnishi S., Yanagawa B., Tanaka K., Miyahara Y., Obata H., Kataoka M., et al. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol 42 (2007) 88-97
15. Kodama M., Matsumoto Y., Fujiwara M., Zhang S., Hanawa H., Itoh E., et al. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 69 (1991) 1042-1050
16. Kodama M., Zhang S.S., Hanawa H., Saeki M., Inomata T., Suzuki K., et al. Effects of 15-deoxyspergualin on experimental autoimmune giant cell myocarditis of the rat. Circulation 91 (1995) 1116-1122
17. Kodama M., Hanawa H., Saeki M., Hosono H., Inomata T., Suzuki K., et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 75 (1994) 278-284
18. Blanas E., Davey G.M., Carbone F.R., and Heath W.R. A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol 164 (2000) 2890-2896
19. Dembic Z., Schenck K., and Bogen B. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells. Proc Natl Acad Sci U S A 97 (2000) 2697-2702
20. Warren T.L., Bhatia S.K., Acosta A.M., Dahle C.E., Ratliff T.L., Krieg A.M., et al. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells. J Immunol 165 (2000) 6244-6251
21. Porgador A., Snyder D., and Gilboa E. Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156 (1996) 2918-2926
22. Reichardt P., Dornbach B., and Gunzer M. The molecular makeup and function of regulatory and effector synapses. Immunol Rev 218 (2007) 165-177
23. Ruedl C., Kopf M., and Bachmann M.F. CD8 T cells mediate CD40 independent maturation of dendritic cells in vivo. J Exp Med 189 (1999) 1875-1884
24. Aloisi F., De Simone R., Columba-Cabezas S., Penna G., and Adorini L. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J Immunol 164 (2000) 1705-1712
25. Zinyama R.B., Bancroft G.J., and Sigola L.B. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-α and interleukin-10. Immunology 104 (2001) 439-446
26. Guermonprez P., Ladant D., Karimova G., Ullmann A., and Leclerc C. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J Immunol 162 (1999) 1910-1916
27. Eriksson U., Ricci R., Hunziker L., Kurrer M.O., Oudit G.Y., Watts T.H., et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9 (2003) 1484-1490
28. Zhao Y.Y., Sawyer D.R., Baliga R.R., Opel D.J., Han X., Marchionni M.A., et al. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 273 (1998) 10261-10269
29. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697-705
30. Li Y., Heuser J.S., Kosanke S.D., Hemric M., and Cunningham M.W. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J Immunol 172 (2004) 3225-3234
31. Okura Y., Takeda K., Honda S., Hanawa H., Watanabe H., Kodama M., et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res 82 (1998) 1035-1042
32. Smith S.C., and Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 147 (1991) 2141-2147
33. Kodama M., matsumoto Y., Fujiwara M., Masani F., Izumi T., and Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57 (1990) 250-262
34. Maisel A., Cesario D., Baird S., Rehman J., Haghighi P., and Carter S. Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ Res 82 (1998) 458-463
35. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science 248 (1990) 1349-1356
36. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
37. Oliveira-dos-Santos A.J., Ho A., Tada Y., Lafaille J.J., Tonegawa S., Mak T.W., et al. CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis. J Immunol 162 (1999) 4490-4495
38. Chang T.T., Jabs C., Sobel R.A., Kuchroo V.K., and Sharpe A.H. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J Exp Med 190 (1999) 733-740
39. Tang A., Judge T.A., Nickoloff B.J., and Turka L.A. Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J Immunol 157 (1996) 117-125
40. Finck B.K., Linsley P.S., and Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 265 (1994) 1225-1227
41. Seko Y., Takahashi N., Azuma M., Yagita H., Okumura K., and Yazaki Y. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on murine acute myocarditis caused by coxsackievirus B3. Circ Res 82 (1998) 613-618
42. Seko Y., Takahashi N., Azuma M., Yagita H., Okumura K., and Yazaki Y. Expression of costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD40L/B7-1 monoclonal antibodies. Circ Res 83 (1998) 463-469
43. Seko Y., Takahashi N., Yagita H., Okumura K., Azuma M., and Yazaki Y. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3. J Pathol 188 (1999) 107-112
44. Youssef S., Stüve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84
45. Okura Y., Yamamoto T., Goto S., Inomata T., Hirono S., Hanawa H., et al. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 29 (1997) 491-502
46. Tang Z., McGowan B.S., Huber S.A., McTiernan C.F., Addya S., Surrey S., et al. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. J Mol Cell Cardiol 36 (2004) 515-530
47. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179 (1994) 1109-1118
48. Trevejo J.M., Marino M.W., Philpott N., Josien R., Richards E.C., Elkon K.B., et al. TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci USA 98 (2001) 12162-12167
49. Fujii S., Liu K., Smith C., Bonito A.J., and Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199 (2004) 1607-1618
50. Di Napoli P., Antonio Taccardi A., Grilli A., Spina R., Felaco M., Barsotti A., et al. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc Res 51 (2001) 283-293
51. Penumathsa S.V., Thirunavukkarasu M., Koneru S., Juhasz B., Zhan L., Pant R., et al. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol 42 (2007) 508-516